Kurokawa, S., Tomita, Y., Doi, K., Iwata, S., Seino, Y., Nomura, M., Ozaki, M. (2014). Clinical features and risk assessment for cardiac surgery in adult congenital heart disease: Three years at a single Japanese center. test, 30(2), 203-210. doi: 10.1016/j.egja.2013.12.004
Satoshi Kurokawa; Yuko Tomita; Kenji Doi; Shihoko Iwata; Yusuke Seino; Minoru Nomura; Makoto Ozaki. "Clinical features and risk assessment for cardiac surgery in adult congenital heart disease: Three years at a single Japanese center". test, 30, 2, 2014, 203-210. doi: 10.1016/j.egja.2013.12.004
Kurokawa, S., Tomita, Y., Doi, K., Iwata, S., Seino, Y., Nomura, M., Ozaki, M. (2014). 'Clinical features and risk assessment for cardiac surgery in adult congenital heart disease: Three years at a single Japanese center', test, 30(2), pp. 203-210. doi: 10.1016/j.egja.2013.12.004
Kurokawa, S., Tomita, Y., Doi, K., Iwata, S., Seino, Y., Nomura, M., Ozaki, M. Clinical features and risk assessment for cardiac surgery in adult congenital heart disease: Three years at a single Japanese center. test, 2014; 30(2): 203-210. doi: 10.1016/j.egja.2013.12.004

Clinical features and risk assessment for cardiac surgery in adult congenital heart disease: Three years at a single Japanese center

Egyptian Journal of Anaesthesia
Volume 30, Issue 2, April 2014, Pages 203-210    PDF (712.4 K)
DOI: 10.1016/j.egja.2013.12.004
Authors
Satoshi Kurokawa; Yuko Tomita; Kenji Doi; Shihoko Iwata; Yusuke Seino; Minoru Nomura; Makoto Ozaki
Abstract
Purpose
The aims of our study are twofold: first, to retrospectively identify the demographic characteristics and outcomes in cardiac surgery for adult congenital heart disease (ACHD); second, to explore whether certain preoperative examinations are useful for assessing the risk of perioperative mortality and morbidity.
Methods
Ninety-two ACHD patients who underwent cardiac surgery from 2009 to 2011 were enrolled in the study. The subjects were classified into three groups based on the complexity of the ACHD. We retrospectively collected data on demographics, operations, and postoperative courses. We also collected the results of examinations performed in the three months leading up to the cardiac surgery, including exercise tolerance testing and measurement of brain natriuretic peptide (BNP).
Results
The 30-day mortality was 3.3%. A remarkable discrepancy was found between subjective assessment and the severity of exercise intolerance by exercise tolerance testing. The NYHA class was 1 or 2 in all but one of 13 patients with moderate-severe exercise intolerance and a high mortality/major complication rate (53.8%). Patients with BNP  100 pg/ml had a significantly higher mortality/major complication rate than patients with BNP < 100 (34.8% vs. 11.5%,  < 0.05), but the sensitivity (53.3%) and positive predictive value (34.8%) were not high enough in themselves to identify patients at high risk of poor outcome.
Conclusion
Cardiac surgery could be safely performed in most ACHD cases. Exercise tolerance testing can be useful in identifying patients at high risk of mortality or major complications. BNP can be valuable in predicting poor outcomes after cardiac surgery.
Keywords
Adult congenital heart disease (ACHD); cardiac surgery; Clinical feature; Exercise tolerance testing; Brain natriuretic peptide (BNP)
Statistics
Article View: 11
PDF Download: 11